» Authors » Ida Pucci-Minafra

Ida Pucci-Minafra

Explore the profile of Ida Pucci-Minafra including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 313
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Buttacavoli M, Di Cara G, Roz E, Pucci-Minafra I, Feo S, Cancemi P
Int J Mol Sci . 2021 Nov; 22(22). PMID: 34830271
Colorectal cancer (CRC) develops by genetic and epigenetic alterations. However, the molecular mechanisms underlying metastatic dissemination remain unclear and could benefit from multi-omics investigations of specific protein families. Matrix metalloproteinases...
2.
Buttacavoli M, Di Cara G, DAmico C, Geraci F, Pucci-Minafra I, Feo S, et al.
Biology (Basel) . 2021 Apr; 10(3). PMID: 33810095
Heat shock proteins (HSPs) are a well-characterized molecular chaperones protein family, classified into six major families, according to their molecular size. A wide range of tumors have been shown to...
3.
Buttacavoli M, Albanese N, Roz E, Pucci-Minafra I, Feo S, Cancemi P
Int J Mol Sci . 2020 May; 21(9). PMID: 32353950
Colon cancer is an aggressive tumor form with a poor prognosis. This study reports a comparative proteomic analysis performed by using two-dimensional differential in-gel electrophoresis (2D-DIGE) between 26 pooled colon...
4.
Cancemi P, Buttacavoli M, Di Cara G, Albanese N, Bivona S, Pucci-Minafra I, et al.
Oncotarget . 2018 Jul; 9(49):29064-29081. PMID: 30018736
The S100 gene family is the largest subfamily of calcium binding proteins of EF-hand type, expressed in tissue and cell-specific manner, acting both as intracellular regulators and extracellular mediators. There...
5.
Pucci-Minafra I, Di Cara G, Musso R, Cancemi P, Albanese N, Roz E, et al.
Proteomes . 2017 Jul; 5(3). PMID: 28686225
The present investigation has been conducted on one hundred tissue fragments of breast cancer, collected and immediately cryopreserved following the surgical resection. The specimens were selected from patients with invasive...
6.
Tomasello L, Musso R, Cillino G, Pitrone M, Pizzolanti G, Coppola A, et al.
Stem Cell Res Ther . 2016 Aug; 7(1):106. PMID: 27510649
No abstract available.
7.
Tomasello L, Musso R, Cillino G, Pitrone M, Pizzolanti G, Coppola A, et al.
Stem Cell Res Ther . 2016 Jun; 7(1):83. PMID: 27296060
Background: In regenerative medicine the maintenance of stem cell properties is of crucial importance. Ageing is considered a cause of reduced stemness capability. The limbus is a stem niche of...
8.
Di Cara G, Marengo G, Albanese N, Marabeti M, Musso R, Cancemi P, et al.
Anticancer Res . 2013 Feb; 33(2):489-503. PMID: 23393341
Background: The Human Epidermal Growth Factor Receptor 2 (HER-2), overexpressed in 25-30% of breast carcinomas (BC), is the therapeutic target for trastuzumab, a recombinant humanized monoclonal antibody. The initial response...
9.
Musso R, Di Cara G, Albanese N, Marabeti M, Cancemi P, Martini D, et al.
J Proteomics . 2013 Feb; 90:115-25. PMID: 23385357
Thyroid carcinomas account for a minority of all malignant tumours but, after those of the gonads, they represent the most common forms of endocrine cancers. They include several types, among...
10.
Cancemi P, Di Cara G, Albanese N, Costantini F, Marabeti M, Musso R, et al.
Proteomics Clin Appl . 2012 May; 6(7-8):364-73. PMID: 22641350
Purpose: The present study reports for the first time a large-scale proteomic screening of the occurrence, subcellular localization and relative quantification of the S100A7 protein among a group of 100...